Albany, New York, May 25, 2018: A new research study titled, “Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025” has been added to the research repository of Market Research Reports Search Engine (MRRSE). According to the research study, the global methicillin-resistant staphylococcus aureus (MRSA) market is likely to grow at a CAGR of 3.2% through 2025. In terms of revenue, the market is projected to reach nearly US$ 4 Bn in revenues by the end of the forecast period.
The research steady offers in-depth insights on the key factors that are likely to provide an impetus to the growth of the methicillin-resistant staphylococcus aureus drugs market during the assessment period. According to the research study, increasing prevalence of MRSA is one of the key factors driving the growth of the market. Growing emphasis on diagnosing MRSA infection at an early stage is also likely to provide an impetus to growth of the market during the assessment period.
In addition to these factors, demand for methicillin-resistant staphylococcus aureus drugs is also driven by favorable government policies towards offering high-quality care and services to patients suffering from methicillin-resistant staphylococcus aureus drugs. Manufacturers can leverage the emerging opportunities in this sector to consolidate their position.
In a bid to offer readers with in-depth insights and analysis, the research study has segmented the market on the basis of drug class, distribution channel, and route of administration. Region-wise analysis and insights is also offered in the research report for the perusal of readers. By drug class, demand for lipopeptide continues to remain the highest, and it is likely that this segment will continue to gain traction during the assessment period.
On the basis of route of administration, the key segments include oral and parenteral. Between these segments, demand of parenteral drugs is significantly higher, and it is highly likely that this segment will remain preferred over the forecast period. The key distribution channels in the methicillin-resistant staphylococcus aureus (MRSA) drugs market include hospital pharmacy, online pharmacy, and retail pharmacy. According to the research study, growing number of multispecialty hospitals, combined with proliferation of distribution channels is likely to provide an impetus to demand during the assessment period.
By region, North America is likely to remain one of the leading markets for methicillin-resistant staphylococcus aureus (MRSA) drugs. The demand for these drugs in North America is likely to remain concentrated in the US. In addition to North America, the other key regions for methicillin-resistant staphylococcus aureus drugs market include Asia Pacific and Europe.
Some of the leading players in the market have been profiled in detail in the research study. According to the report, Basilea Pharmaceutica Ltd., Theravance Biopharma, Allergan, The Medicines Company, Merck & Co., Inc., and Pfizer, Inc.
Browse Full Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Report with TOC : https://www.mrrse.com/mrsa-drugs-market
Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.
MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.
90, State Street
Albany, NY – 12207